scholarly article | Q13442814 |
P50 | author | Carly G K Ziegler | Q84983703 |
Donna L. Farber | Q51017491 | ||
Ronald G Collman | Q79946690 | ||
P2093 | author name string | David Artis | |
E John Wherry | |||
Theresa Alenghat | |||
Joshua M Diamond | |||
Ananda W Goldrath | |||
Michael C Abt | |||
Masaru Kubota | |||
Damian Turner | |||
Taheri Sathaliyawala | |||
Gregory F Sonnenberg | |||
Laurel A Monticelli | |||
Travis A Doering | |||
Jill M Angelosanto | |||
Brian J Laidlaw | |||
Cliff Y Yang | |||
P2860 | cites work | Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 |
Systemically dispersed innate IL-13-expressing cells in type 2 immunity | Q24623563 | ||
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity | Q24630261 | ||
IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses | Q24630608 | ||
Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22 | Q24648620 | ||
Exploration, normalization, and summaries of high density oligonucleotide array probe level data | Q27861098 | ||
A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity | Q28299539 | ||
Pulmonary fibrosis: pathogenesis, etiology and regulation | Q28388425 | ||
Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity | Q28512981 | ||
GenePattern 2.0 | Q29614171 | ||
Intestinal mucosal barrier function in health and disease | Q29618086 | ||
Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells | Q29619771 | ||
IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors | Q33656197 | ||
Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. | Q33854381 | ||
Epithelial repair mechanisms in the lung | Q33916933 | ||
Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity | Q33934522 | ||
Interleukin-22 (IL-22) production by pulmonary Natural Killer cells and the potential role of IL-22 during primary influenza virus infection | Q33964145 | ||
Innate immune cell populations function as initiators and effectors in Th2 cytokine responses | Q34143992 | ||
The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. | Q34152180 | ||
RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells | Q34441341 | ||
CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. | Q34562235 | ||
Diverse roles of inhibitor of differentiation 2 in adaptive immunity | Q34700661 | ||
Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. | Q36157993 | ||
Cytokines and growth factors in airway remodeling in asthma. | Q36919505 | ||
Immunologic and inflammatory mechanisms that drive asthma progression to remodeling | Q37105324 | ||
Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. | Q37159089 | ||
Immunity to respiratory viruses | Q37309418 | ||
Transcriptional regulator Id2 controls survival of hepatic NKT cells | Q37429039 | ||
Roles and regulation of Thy-1, a context-dependent modulator of cell phenotype | Q37473336 | ||
Functional biology of the IL-22-IL-22R pathway in regulating immunity and inflammation at barrier surfaces | Q37804993 | ||
Epithelial progenitor cells in lung development, maintenance, repair, and disease | Q37884611 | ||
Gene expression profiling of target genes in ventilator-induced lung injury | Q38314691 | ||
Infection with influenza virus induces IL-33 in murine lungs | Q39530296 | ||
Cell-intrinsic defects in the proliferative response of antiviral memory CD8 T cells in aged mice upon secondary infection | Q39718825 | ||
Tissue remodeling induced by hypersecreted epidermal growth factor and amphiregulin in the airway after an acute asthma attack | Q39778092 | ||
Interleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue. | Q41893697 | ||
Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. | Q41904687 | ||
RORγt+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota | Q46167903 | ||
Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense | Q46197286 | ||
Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells | Q46231038 | ||
Transcriptional regulator Id2 mediates CD8+ T cell immunity. | Q46760945 | ||
Modulation of lipopolysaccharide-induced gene transcription and promotion of lung injury by mechanical ventilation | Q47741264 | ||
FcepsilonRI-mediated amphiregulin production by human mast cells increases mucin gene expression in epithelial cells | Q47852749 | ||
Extracting biological meaning from large gene lists with DAVID. | Q51795802 | ||
Amphiregulin expression in human mast cells and its effect on the primary human lung fibroblasts. | Q54681876 | ||
Amphiregulin attenuates bleomycin-induced pneumopathy in mice. | Q54709389 | ||
Regulation of Cytokine Secretion in Human CD127+ LTi-like Innate Lymphoid Cells by Toll-like Receptor 2 | Q58478673 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | tissue homeostasis | Q14873636 |
P304 | page(s) | 1045-1054 | |
P577 | publication date | 2011-11-01 | |
P1433 | published in | Nature Immunology | Q1071725 |
P1476 | title | Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus | |
P478 | volume | 12 |
Q90182354 | A CCL1/CCR8-dependent feed-forward mechanism drives ILC2 functions in type 2-mediated inflammation |
Q36155521 | A Distinct Function of Regulatory T Cells in Tissue Protection |
Q64076022 | A Macrophage-Pericyte Axis Directs Tissue Restoration via Amphiregulin-Induced Transforming Growth Factor Beta Activation |
Q59350165 | A Major Population of Functional KLRG1 ILC2s in Female Lungs Contributes to a Sex Bias in ILC2 Numbers |
Q89055227 | A Metabolite-Triggered Tuft Cell-ILC2 Circuit Drives Small Intestinal Remodeling |
Q40743958 | A Novel CD4(+) T Cell-Dependent Murine Model of Pneumocystis-driven Asthma-like Pathology |
Q63976717 | A Novel Hybrid Cytokine IL233 Mediates regeneration following Doxorubicin-Induced Nephrotoxic Injury |
Q48208624 | A Proinflammatory Role of Type 2 Innate Lymphoid Cells in Murine Immune-Mediated Hepatitis. |
Q97644534 | A Truncated Form of HpARI Stabilizes IL-33, Amplifying Responses to the Cytokine |
Q48231667 | A catch-22: Interleukin-22 and cancer |
Q39031358 | A committed precursor to innate lymphoid cells |
Q37591319 | A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis |
Q53070656 | A network map of IL-33 signaling pathway. |
Q37397800 | A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. |
Q34390308 | A special population of regulatory T cells potentiates muscle repair |
Q38170180 | A tale of two cytokines: IL-17 and IL-22 in asthma and infection |
Q38008350 | AHR and the Transcriptional Regulation of Type-17/22 ILC. |
Q47736517 | AKT2 Regulates Pulmonary Inflammation and Fibrosis via Modulating Macrophage Activation |
Q36057251 | Abrogation of airway hyperresponsiveness but not inflammation by rho kinase insufficiency |
Q46057361 | Absence of Toll-IL-1 receptor 8/single immunoglobulin IL-1 receptor-related molecule reduces house dust mite-induced allergic airway inflammation in mice |
Q92511318 | Activation of Resolution Pathways to Prevent and Fight Chronic Inflammation: Lessons From Asthma and Inflammatory Bowel Disease |
Q51751177 | Activation of Type 3 innate lymphoid cells and interleukin 22 secretion in the lungs during Streptococcus pneumoniae infection. |
Q42576928 | Activation of group 2 innate lymphoid cells: a new role for cysteinyl leukotrienes |
Q57791281 | Activations of group 2 innate lymphoid cells depend on endotypes of chronic rhinosinusitis |
Q34262084 | Acute clearance of human metapneumovirus occurs independently of natural killer cells |
Q56996774 | Advancements in Host-Based Interventions for Influenza Treatment |
Q42424364 | Airway epithelial NF-κB activation promotes the ability to overcome inhalational antigen tolerance |
Q93352014 | Airway innate lymphoid cells in the induction and regulation of allergy |
Q30241037 | Alarmins and central nervous system inflammation in HIV-associated neurological disorders |
Q88959784 | All along the watchtower: group 2 innate lymphoid cells in allergic responses |
Q36636578 | Allergen-Dependent Differences in ILC2s Frequencies in Patients With Allergic Rhinitis |
Q47915714 | Allergen-induced Increases in Sputum Levels of Group 2 Innate Lymphoid Cells in Subjects with Asthma |
Q90626863 | Allergic Immune Diseases and the Risk of Mortality Among Patients Hospitalized for Acute Infection |
Q39402866 | Allergic airway inflammation: key players beyond the Th2 cell pathway. |
Q41190858 | Allergic host defences |
Q35164318 | Allergic inflammation--innately homeostatic |
Q58106783 | Alteration of Flt3-Ligand-dependent de novo generation of conventional dendritic cells during influenza infection contributes to respiratory bacterial superinfection |
Q47132488 | Alternative activation generates IL-10 producing type 2 innate lymphoid cells |
Q52927623 | Alveolar Epithelial Cell-Derived Mediators: Potential Direct Regulators of Large Airway and Vascular Responses. |
Q54251521 | Ambient ozone and influenza transmissibility in Hong Kong. |
Q98159044 | Ambiguous roles and potential therapeutic strategies of innate lymphoid cells in different types of tumor |
Q57049816 | Amphiregulin-producing γδ T cells are vital for safeguarding oral barrier immune homeostasis |
Q64963771 | An Essential Role of Innate Lymphoid Cells in the Pathophysiology of Graft-vs.-Host Disease. |
Q39000453 | An Update on Lymphocyte Subtypes in Asthma and Airway Disease |
Q40519001 | An early innate response underlies severe influenza-induced exacerbations of asthma in a novel steroid-insensitive and anti-IL-5-responsive mouse model |
Q38233854 | An overview of the role of innate lymphoid cells in gut infections and inflammation |
Q41605623 | Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma |
Q34454614 | Antiviral B cell and T cell immunity in the lungs. |
Q39402910 | Are ILC2s Jekyll and Hyde in airway inflammation? |
Q36917941 | Arginase 1 is an innate lymphoid-cell-intrinsic metabolic checkpoint controlling type 2 inflammation |
Q35402962 | Asthma and the flu: a tricky two-step |
Q30363298 | Asthma increases susceptibility to heterologous but not homologous secondary influenza |
Q35115486 | At the bedside: the emergence of group 2 innate lymphoid cells in human disease |
Q35115465 | At the bench: understanding group 2 innate lymphoid cells in disease. |
Q26765927 | Avian Influenza Viruses, Inflammation, and CD8(+) T Cell Immunity |
Q60709804 | BCL11B mutations in patients affected by a neurodevelopmental disorder with reduced type 2 innate lymphoid cells |
Q38078465 | Bacterial superinfection following lung inflammatory disorders. |
Q39247966 | Basophil-derived amphiregulin is essential for UVB irradiation-induced immune suppression. |
Q37520281 | Basophils and allergic inflammation |
Q26865509 | Beneficial autoimmunity at body surfaces - immune surveillance and rapid type 2 immunity regulate tissue homeostasis and cancer |
Q90707615 | Beta Cell Dedifferentiation Induced by IRE1α Deletion Prevents Type 1 Diabetes |
Q33759935 | Beyond NK cells: the expanding universe of innate lymphoid cells. |
Q43058864 | Biliary epithelial injury-induced regenerative response by IL-33 promotes cholangiocarcinogenesis from peribiliary glands |
Q33808159 | Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation |
Q41966864 | Bim controls IL-15 availability and limits engagement of multiple BH3-only proteins |
Q90841499 | Biology and regulation of IL-2: from molecular mechanisms to human therapy |
Q36305994 | Blockade of IL-10 signaling during bacillus Calmette-Guérin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-γ and IL-17 responses and increases protection to Mycobacterium tuberculosis infection |
Q33958449 | Blowing on embers: commensal microbiota and our immune system |
Q37018469 | Bone Marrow CD11c+ Cell-Derived Amphiregulin Promotes Pulmonary Fibrosis |
Q92309134 | CD200R1 regulates eosinophilia during pulmonary fungal infection in mice |
Q38577294 | CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. |
Q35586367 | Cell recruitment by amnion chorion grafts promotes neovascularization. |
Q40398567 | Cellular Innate Immunity: An Old Game with New Players. |
Q28079497 | Cellular and molecular regulation of innate inflammatory responses |
Q51105848 | Cellular comparison of sinus mucosa vs polyp tissue from a single sinus cavity in chronic rhinosinusitis. |
Q92885953 | Cellular crosstalk in the development and regeneration of the respiratory system |
Q38070793 | Cellular immune reactions in the lung |
Q34442444 | Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells |
Q52626495 | Characterisation of innate lymphoid cell populations at different sites in mice with defective T cell immunity. |
Q31034892 | Characterization and Quantification of Innate Lymphoid Cell Subsets in Human Lung |
Q39034672 | Characterization of Group 2 Innate Lymphoid Cells in Allergic Airway Inflammation Models in the Mouse |
Q30275187 | Characterization of meningeal type 2 innate lymphocytes and their response to CNS injury |
Q33604481 | Chitin activates parallel immune modules that direct distinct inflammatory responses via innate lymphoid type 2 and γδ T cells |
Q90068954 | Circadian control of lung inflammation in influenza infection |
Q36802513 | Club cells surviving influenza A virus infection induce temporary nonspecific antiviral immunity |
Q35329384 | Collaborative interactions between type 2 innate lymphoid cells and antigen-specific CD4+ Th2 cells exacerbate murine allergic airway diseases with prominent eosinophilia |
Q38882799 | Colonization and effector functions of innate lymphoid cells in mucosal tissues |
Q92721819 | Compartmentalized effects of aging on group 2 innate lymphoid cell development and function |
Q39012808 | Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients. |
Q99237827 | Contributions of IL-33 in Non-hematopoietic Lung Cells to Obstructive Lung Disease |
Q27026513 | Control of adaptive immunity by the innate immune system |
Q36440299 | Controlling the burn and fueling the fire: defining the role for the alarmin interleukin-33 in alloimmunity |
Q37716155 | Conventional NK cells can produce IL-22 and promote host defense in Klebsiella pneumoniae pneumonia |
Q36387235 | Costimulation Endows Immunotherapeutic CD8 T Cells with IL-36 Responsiveness during Aerobic Glycolysis |
Q37152573 | Critical role of p38 and GATA3 in natural helper cell function |
Q37996923 | Cross-roads in the lung: immune cells and tissue interactions as determinants of allergic asthma |
Q35785264 | Cross-talk between type 3 innate lymphoid cells and the gut microbiota in inflammatory bowel disease |
Q28077126 | Crosstalk between Innate Lymphoid Cells and Other Immune Cells in the Tumor Microenvironment |
Q35439783 | Crucial and diverse role of the interleukin-33/ST2 axis in infectious diseases |
Q35878914 | Current and future biomarkers in allergic asthma |
Q30612542 | Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells |
Q50527654 | Cutting Edge: Innate Lymphoid Cells Suppress Homeostatic T Cell Expansion in Neonatal Mice. |
Q37358129 | Cutting edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in mice. |
Q34455625 | Cutting edge: maresin-1 engages regulatory T cells to limit type 2 innate lymphoid cell activation and promote resolution of lung inflammation |
Q55025675 | Cyclic AMP signaling enhances lipopolysaccharide sensitivity and interleukin-33 production in RAW264.7 macrophages. |
Q92488411 | Cyclooxygenase 2 augments osteoblastic but suppresses chondrocytic differentiation of CD90+ skeletal stem cells in fracture sites |
Q42118581 | Cysteinyl leukotriene E4 activates human group 2 innate lymphoid cells and enhances the effect of prostaglandin D2 and epithelial cytokines |
Q91142640 | Cysteinyl leukotriene receptor 2 drives lung immunopathology through a platelet and high mobility box 1-dependent mechanism |
Q50317364 | Cytokine Networks between Innate Lymphoid Cells and Myeloid Cells. |
Q27007655 | Cytokine-induced cytokine production by conventional and innate lymphoid cells |
Q91636313 | Cytokines and beyond: Regulation of innate immune responses during helminth infection |
Q37695034 | Damage-associated molecular patterns stimulate interleukin-33 expression in nasal polyp epithelial cells |
Q26861554 | Deciphering the transcriptional switches of innate lymphoid cell programming: the right factors at the right time |
Q37688505 | Deficiency of melanoma differentiation-associated protein 5 results in exacerbated chronic postviral lung inflammation |
Q55438060 | Dephosphorylated Polymerase I and Transcript Release Factor Prevents Allergic Asthma Exacerbations by Limiting IL-33 Release. |
Q36348351 | Depletion of fat-resident Treg cells prevents age-associated insulin resistance |
Q64100931 | Detecting virus-specific effects on post-infection temporal gene expression |
Q26862916 | Development and function of group 2 innate lymphoid cells |
Q39402872 | Development of allergic immunity in early life. |
Q38872148 | Development of innate lymphoid cells |
Q38252608 | Development, differentiation, and diversity of innate lymphoid cells |
Q50424174 | Developmental mechanisms and adult stem cells for therapeutic lung regeneration. |
Q36288553 | Differential regulation of C5a receptor 1 in innate immune cells during the allergic asthma effector phase |
Q39065203 | Disease tolerance and immunity in host protection against infection |
Q49662048 | Disease tolerance: concept and mechanisms. |
Q37171759 | Distinctive Leukocyte Subpopulations According to Organ Type in Cynomolgus Macaques |
Q36693141 | Diversity, function, and transcriptional regulation of gut innate lymphocytes |
Q39384272 | Dynamic balance between master transcription factors determines the fates and functions of CD4 T cell and innate lymphoid cell subsets. |
Q42176534 | Dynamic role of epithelium-derived cytokines in asthma |
Q40092134 | Dynamics of influenza-induced lung-resident memory T cells underlie waning heterosubtypic immunity |
Q35196768 | Dynamics of lung defense in pneumonia: resistance, resilience, and remodeling. |
Q28075218 | Dysregulation of Group 3 Innate Lymphoid Cells in the Pathogenesis of Inflammatory Bowel Disease |
Q33913781 | EGFR activation suppresses respiratory virus-induced IRF1-dependent CXCL10 production |
Q38699312 | Early Postnatal Secondhand Smoke Exposure Disrupts Bacterial Clearance and Abolishes Immune Responses in Muco-Obstructive Lung Disease. |
Q33824093 | Early local immune defences in the respiratory tract |
Q97067682 | Editorial: The Role of Innate Lymphoid Cells in Mucosal Immunity |
Q91588797 | Effects of Air Pollution on Lung Innate Lymphoid Cells: Review of In Vitro and In Vivo Experimental Studies |
Q34142426 | Effects of mycobacteria major secretion protein, Ag85B, on allergic inflammation in the lung |
Q89714182 | Elevated circulating Th2 but not group 2 innate lymphoid cell responses characterize canine atopic dermatitis |
Q39226501 | Emerging Roles of IL-33/ST2 Axis in Renal Diseases. |
Q37346684 | Emerging concepts and future challenges in innate lymphoid cell biology |
Q38774563 | Emerging concepts: mast cell involvement in allergic diseases. |
Q36687542 | Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair. |
Q47719552 | Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implications. |
Q35740929 | Enhanced circulating ILC2s accompany by upregulated MDSCs in patients with asthma. |
Q34111924 | Enhanced innate type 2 immune response in peripheral blood from patients with asthma |
Q97067660 | Eomes Expression Defines Group 1 Innate Lymphoid Cells During Metastasis in Human and Mouse |
Q90208256 | Eosinophil accumulation in postnatal lung is specific to the primary septation phase of development |
Q41297752 | Epidermal Expression and Regulation of Interleukin-33 during Homeostasis and Inflammation: Strong Species Differences |
Q36520488 | Epidermal growth factor receptor signalling regulates granulocyte-macrophage colony-stimulating factor production by airway epithelial cells and established allergic airway disease |
Q36080691 | Epithelial-intrinsic IKKα expression regulates group 3 innate lymphoid cell responses and antibacterial immunity. |
Q36950405 | Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-5+ and IL-13+ type 2 innate lymphoid cells |
Q33874975 | Establishment and function of tissue-resident innate lymphoid cells in the skin |
Q39358786 | Exocrine Gland Morphogenesis: Insights into the Role of Amphiregulin from Development to Disease |
Q90062026 | Exogenous Interleukin-33 Contributes to Protective Immunity via Cytotoxic T-Cell Priming against Mucosal Influenza Viral Infection |
Q36475881 | Expansion of CD25+ Innate Lymphoid Cells Reduces Atherosclerosis |
Q39425975 | Fetal CD103+ IL-17-Producing Group 3 Innate Lymphoid Cells Represent the Dominant Lymphocyte Subset in Human Amniotic Fluid. |
Q38947692 | First-Breath-Induced Type 2 Pathways Shape the Lung Immune Environment |
Q35916424 | Flt3 Ligand Regulates the Development of Innate Lymphoid Cells in Fetal and Adult Mice. |
Q92215594 | Functional interactions between innate lymphoid cells and adaptive immunity |
Q28085582 | Future Research Directions in Asthma. An NHLBI Working Group Report |
Q47105198 | GATA3 Regulates the Development and Functions of Innate Lymphoid Cell Subsets at Multiple Stages |
Q33711562 | GATA3: a master of many trades in immune regulation |
Q37576715 | Gata3 drives development of RORγt+ group 3 innate lymphoid cells. |
Q38773340 | Grass pollen immunotherapy: where are we now. |
Q39381981 | Group 2 ILCs: A way of enhancing immune protection against human helminths? |
Q89209470 | Group 2 Innate Lymphoid Cells (ILC2s) Are Key Mediators of the Inflammatory Response in Polymicrobial Sepsis |
Q64108158 | Group 2 Innate Lymphoid Cells Are Redundant in Experimental Renal Ischemia-Reperfusion Injury |
Q53818897 | Group 2 Innate Lymphoid Cells in Pulmonary Immunity and Tissue Homeostasis. |
Q89805617 | Group 2 Innate Lymphoid Cells: Central Players in a Recurring Theme of Repair and Regeneration |
Q30417087 | Group 2 innate lymphoid cell production of IL-5 is regulated by NKT cells during influenza virus infection |
Q51074774 | Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia. |
Q42093185 | Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation |
Q38573631 | Group 2 innate lymphoid cells in disease |
Q38312434 | Group 2 innate lymphoid cells in health and disease |
Q38122453 | Group 2 innate lymphoid cells in lung inflammation |
Q27021302 | Group 2 innate lymphoid cells in the lung |
Q36389520 | Group 2 innate lymphoid cells license dendritic cells to potentiate memory TH2 cell responses |
Q36563818 | Group 2 innate lymphoid cells mediate ozone-induced airway inflammation and hyperresponsiveness in mice |
Q35660131 | Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity |
Q52671128 | Group 2 innate lymphoid cells protect lung endothelial cells from pyroptosis in sepsis. |
Q50898097 | Group 2 innate lymphoid cells show up in the skin. |
Q36421549 | Group 2 innate lymphoid cells utilize the IRF4-IL-9 module to coordinate epithelial cell maintenance of lung homeostasis |
Q27021604 | Group 2 innate lymphoid cells: new players in human allergic diseases |
Q64071688 | Group 3 ILCs: Peacekeepers or Troublemakers? What's Your Gut Telling You?! |
Q92548384 | Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis |
Q58569290 | Group II innate lymphoid cells and microvascular dysfunction from pulmonary titanium dioxide nanoparticle exposure |
Q39167526 | Guards at the gate: physiological and pathological roles of tissue-resident innate lymphoid cells in the lung |
Q37152701 | Hallmarks of Tissue-Resident Lymphocytes |
Q59128967 | Hallmarks of primate lentiviral immunodeficiency infection recapitulate loss of innate lymphoid cells |
Q90441910 | Harnessing innate immunity in cancer therapy |
Q30413616 | Helix-loop-helix factor inhibitor of differentiation 3 regulates interleukin-5 expression and B-1a B cell proliferation |
Q94522042 | Heterogeneity in the initiation, development and function of type 2 immunity |
Q33577368 | Highlights of the advances in basic immunology in 2011. |
Q38229984 | Host protective roles of type 2 immunity: parasite killing and tissue repair, flip sides of the same coin. |
Q57206349 | Host resilience to emerging coronaviruses |
Q57300147 | Host-Parasite Interactions Promote Disease Tolerance to Intestinal Helminth Infection |
Q36910650 | Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection |
Q58781730 | Human Innate Lymphoid Cells: Their Functional and Cellular Interactions in Decidua |
Q48108184 | Human immunology studies using organ donors: Impact of clinical variations on immune parameters in tissues and circulation. |
Q47099669 | Human intrahepatic ILC2 are IL-13positive amphiregulinpositive and their frequency correlates with model of end stage liver disease score. |
Q42266815 | Human skin in the game |
Q85926211 | Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues |
Q26827479 | I-L-C-2 it: type 2 immunity and group 2 innate lymphoid cells in homeostasis |
Q40219134 | ICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s |
Q35196224 | ICOS:ICOS-ligand interaction is required for type 2 innate lymphoid cell function, homeostasis, and induction of airway hyperreactivity. |
Q30402075 | IFN-γ increases susceptibility to influenza A infection through suppression of group II innate lymphoid cells. |
Q51530407 | IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity. |
Q36767462 | IL-12 drives functional plasticity of human group 2 innate lymphoid cells |
Q51430338 | IL-13+ Type 2 Innate Lymphoid Cells Correlate with Asthma Control Status and Treatment Response. |
Q39692981 | IL-22 is essential for lung epithelial repair following influenza infection |
Q36003102 | IL-25 Elicits Innate Lymphoid Cells and Multipotent Progenitor Type 2 Cells That Reduce Renal Ischemic/Reperfusion Injury. |
Q37474764 | IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis. |
Q37125786 | IL-25 simultaneously elicits distinct populations of innate lymphoid cells and multipotent progenitor type 2 (MPPtype2) cells |
Q34979676 | IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential 'inflammatory' type 2 innate lymphoid cells. |
Q90363933 | IL-33 Induces Murine Intestinal Goblet Cell Differentiation Indirectly via Innate Lymphoid Cell IL-13 Secretion |
Q39421781 | IL-33 and the intestine: The good, the bad, and the inflammatory |
Q40265668 | IL-33 contributes to sepsis-induced long-term immunosuppression by expanding the regulatory T cell population. |
Q36512087 | IL-33 drives biphasic IL-13 production for noncanonical Type 2 immunity against hookworms |
Q41081302 | IL-33 induces innate lymphoid cell-mediated airway inflammation by activating mammalian target of rapamycin |
Q28588039 | IL-33 induces nuocytes and modulates liver injury in viral hepatitis. |
Q24633495 | IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G |
Q36008266 | IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions |
Q39673177 | IL-33 promotes innate IFN-γ production and modulates dendritic cell response in LCMV-induced hepatitis in mice |
Q47340483 | IL-33 promotes the egress of group 2 innate lymphoid cells from the bone marrow. |
Q64994327 | IL-33 regulates cytokine production and neutrophil recruitment via the p38 MAPK-activated kinases MK2/3. |
Q35946057 | IL-33-Dependent Endothelial Activation Contributes to Apoptosis and Renal Injury in Orientia tsutsugamushi-Infected Mice |
Q36514695 | IL-33-Dependent Group 2 Innate Lymphoid Cells Promote Cutaneous Wound Healing |
Q40348061 | IL-33-Mediated Expansion of Type 2 Innate Lymphoid Cells Protects from Progressive Glomerulosclerosis |
Q47407422 | IL-33-Responsive Group 2 Innate Lymphoid Cells Are Regulated by Female Sex Hormones in the Uterus |
Q99608351 | IL-33-ST2 axis regulates myeloid cell differentiation and activation enabling effective club cell regeneration |
Q38937386 | IL-33-driven ILC2/eosinophil axis in fat is induced by sympathetic tone and suppressed by obesity |
Q33738493 | IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps |
Q52718173 | IL-33/ST2 axis mediates hyperplasia of intrarenal urothelium in obstructive renal injury. |
Q36960477 | IL-33: a novel danger signal system in atopic dermatitis |
Q39402943 | IL-33: biological properties, functions, and roles in airway disease |
Q37600819 | IL-4-producing ILC2s are required for the differentiation of TH2 cells following Heligmosomoides polygyrus infection. |
Q37397810 | IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation |
Q95840967 | ILC2 Lung-Homing in Cystic Fibrosis Patients: Functional Involvement of CCR6 and Impact on Respiratory Failure |
Q98196889 | ILC2-driven innate immune checkpoint mechanism antagonizes NK cell antimetastatic function in the lung |
Q91279210 | ILC2: at home in the thymus |
Q93345998 | ILC2s - resident lymphocytes pre-adapted to a specific tissue or migratory effectors that adapt to where they move? |
Q89792315 | ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity |
Q38539058 | ILC2s and fungal allergy |
Q54240796 | ILC2s in infectious diseases and organ-specific fibrosis. |
Q90465868 | ILC2s mediate systemic innate protection by priming mucus production at distal mucosal sites |
Q40118341 | ILC2s regulate adaptive Th2 cell functions via PD-L1 checkpoint control. |
Q64076141 | ILC2s-Trailblazers in the Host Response Against Intestinal Helminths |
Q92072232 | ILC2s: New Actors in Tumor Immunity |
Q36520874 | ILC3 GM-CSF production and mobilisation orchestrate acute intestinal inflammation |
Q64066256 | ILC3 function as a double-edged sword in inflammatory bowel diseases |
Q93154469 | Identification of Group 2 Innate Lymphoid Cells in Mouse Lung, Liver, Small Intestine, Bone Marrow, and Mediastinal and Mesenteric Lymph Nodes |
Q90732984 | Imbalance of Circulating Innate Lymphoid Cell Subpopulations in Patients With Septic Shock |
Q38130488 | Immune dysfunction and bacterial coinfections following influenza |
Q39000249 | Immune modules shared by innate lymphoid cells and T cells |
Q35450500 | Immune regulation of metabolic homeostasis in health and disease. |
Q45324307 | Immune responses in influenza A virus and human coronavirus infections: an ongoing battle between the virus and host |
Q35667676 | Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4⁺ T cells |
Q64447844 | Immune‐ and non‐immune‐mediated roles of regulatory T‐cells during wound healing |
Q36155214 | Immunological Signatures after Bordetella pertussis Infection Demonstrate Importance of Pulmonary Innate Immune Cells |
Q27027636 | Immunopathology of inflammatory bowel disease |
Q52771825 | Impact of the genetic variants of GLCCI1 on clinical features of asthmatic patients. |
Q36807908 | Implications for Interleukin-33 in solid organ transplantation |
Q98775560 | Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions |
Q34732937 | Increased frequencies of nuocytes in peripheral blood from patients with Graves' hyperthyroidism. |
Q91597440 | Induction of autophagy in Cx3cr1+ mononuclear cells limits IL-23/IL-22 axis-mediated intestinal fibrosis |
Q37584583 | Inference of immune cell composition on the expression profiles of mouse tissue |
Q36468792 | Inflammatory group 2 innate lymphoid cells |
Q37693528 | Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs |
Q40661474 | Influenza A virus-induced release of interleukin-10 inhibits the anti-microbial activities of invariant natural killer T cells during invasive pneumococcal superinfection |
Q40160725 | Influenza and secondary bacterial infections: threats and treatments |
Q57093925 | Influenza in Asthmatics: For Better or for Worse? |
Q30366650 | Influenza vaccines to control influenza-associated bacterial infection: where do we stand? |
Q52603630 | Influenza-Activated ILC1s Contribute to Antiviral Immunity Partially Influenced by Differential GITR Expression. |
Q64091605 | Inhibition of glutamine metabolism accelerates resolution of acute lung injury |
Q98946074 | Initiating pollen sensitization - complex source, complex mechanisms |
Q60954877 | Innate Immune Cell Suppression and the Link With Secondary Lung Bacterial Pneumonia |
Q99711557 | Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections |
Q47162429 | Innate Lymphoid Cells (ILCs) as Mediators of Inflammation, Release of Cytokines and Lytic Molecules |
Q49920496 | Innate Lymphoid Cells (ILCs): Cytokine Hubs Regulating Immunity and Tissue Homeostasis. |
Q40019073 | Innate Lymphoid Cells Are Depleted Irreversibly during Acute HIV-1 Infection in the Absence of Viral Suppression. |
Q40942694 | Innate Lymphoid Cells Are the Predominant Source of IL-17A during the Early Pathogenesis of Acute Respiratory Distress Syndrome. |
Q47554808 | Innate Lymphoid Cells in HIV/SIV Infections |
Q42683314 | Innate Lymphoid Cells in Intestinal Inflammation |
Q64255314 | Innate Lymphoid Cells in Mucosal Immunity |
Q53796096 | Innate Lymphoid Cells in Tumor Immunity. |
Q58707784 | Innate Lymphoid Cells in the Maternal and Fetal Compartments |
Q64230647 | Innate Lymphoid Cells: A Link between the Nervous System and Microbiota in Intestinal Networks |
Q64084898 | Innate Lymphoid Cells: Expression of PD-1 and Other Checkpoints in Normal and Pathological Conditions |
Q92594507 | Innate Lymphoid Cells: Regulators of Gut Barrier Function and Immune Homeostasis |
Q39402938 | Innate and adaptive type 2 immunity in lung allergic inflammation. |
Q30365302 | Innate immune sensing and response to influenza. |
Q38221348 | Innate immunity in the lung regulates the development of asthma |
Q34465047 | Innate immunity is a key factor for the resolution of inflammation in asthma |
Q33923354 | Innate immunity to influenza virus infection |
Q27010139 | Innate lymphocyte cells in asthma phenotypes |
Q104508254 | Innate lymphoid cell composition associates with COVID-19 disease severity |
Q36390314 | Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease |
Q49980468 | Innate lymphoid cells and allergic disease. |
Q38133877 | Innate lymphoid cells and allergic inflammation |
Q34895926 | Innate lymphoid cells and the skin |
Q35928131 | Innate lymphoid cells and type 2 (th2) mediated immune responses - pathogenic or beneficial? |
Q38500621 | Innate lymphoid cells are pivotal actors in allergic, inflammatory and autoimmune diseases |
Q38872144 | Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis. |
Q49861059 | Innate lymphoid cells at the human maternal-fetal interface in spontaneous preterm labor. |
Q94591730 | Innate lymphoid cells control signaling circuits to regulate tissue-specific immunity |
Q36973089 | Innate lymphoid cells in asthma: Will they take your breath away? |
Q38985676 | Innate lymphoid cells in autoimmunity: emerging regulators in rheumatic diseases. |
Q87718734 | Innate lymphoid cells in defense, immunopathology and immunotherapy |
Q26801315 | Innate lymphoid cells in graft-versus-host disease |
Q38605374 | Innate lymphoid cells in intestinal immunity and inflammation |
Q38810910 | Innate lymphoid cells in secondary lymphoid organs |
Q27012728 | Innate lymphoid cells in the airways |
Q36908615 | Innate lymphoid cells in the initiation, regulation and resolution of inflammation |
Q27023221 | Innate lymphoid cells in the skin |
Q40063411 | Innate lymphoid cells in tissue homeostasis and diseases |
Q38295077 | Innate lymphoid cells in type 2 immune responses |
Q38325566 | Innate lymphoid cells involve in tumorigenesis. |
Q36977474 | Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria |
Q36822687 | Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model |
Q82104147 | Innate lymphoid cells wield a double-edged sword |
Q27026229 | Innate lymphoid cells, possible interaction with microbiota |
Q29617431 | Innate lymphoid cells--a proposal for uniform nomenclature |
Q38071916 | Innate lymphoid cells--how did we miss them? |
Q88990558 | Innate lymphoid cells-key immune integrators of overall body homeostasis |
Q35638915 | Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology |
Q92560950 | Innate lymphoid cells: A potential link between microbiota and immune responses against cancer |
Q36645149 | Innate lymphoid cells: balancing immunity, inflammation, and tissue repair in the intestine. |
Q36059099 | Innate lymphoid cells: critical regulators of allergic inflammation and tissue repair in the lung |
Q38077406 | Innate lymphoid cells: from border protection to the initiation of inflammatory diseases |
Q38643190 | Innate lymphoid cells: major players in inflammatory diseases |
Q38916194 | Innate lymphoid cells: models of plasticity for immune homeostasis and rapid responsiveness in protection. |
Q38622555 | Innate lymphoid cells: the role in respiratory infections and lung tissue damage |
Q36694157 | Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages |
Q33987059 | Innate protection from graft-versus-host disease |
Q26996036 | Innate receptors and cellular defense against pulmonary infections |
Q44622555 | Insight into newly discovered innate immune modulation in atopic dermatitis |
Q28076134 | Insights into Group 2 Innate Lymphoid Cells in Human Airway Disease |
Q35562959 | Integrated innate mechanisms involved in airway allergic inflammation to the serine protease subtilisin |
Q88691581 | Integrative Physiology of Pneumonia |
Q58419491 | Interactions Between Multipotential Stromal Cells (MSCs) and Immune Cells During Bone Healing |
Q38240762 | Interactions between innate and adaptive lymphocytes. |
Q34397537 | Interactions between the intestinal microbiota and innate lymphoid cells. |
Q47552015 | Interactions between the microbiota and innate and innate-like lymphocytes. |
Q40899542 | Interferon and IL-27 antagonize the function of group 2 innate lymphoid cells and type 2 innate immune responses. |
Q40971337 | Interferon-γ constrains cytokine production of group 2 innate lymphoid cells |
Q47591113 | Interleukin (IL)-33 and the IL-1 Family of Cytokines-Regulators of Inflammation and Tissue Homeostasis. |
Q91803464 | Interleukin 1 Receptor-Like 1 (IL1RL1) Promotes Airway Bacterial and Viral Infection and Inflammation |
Q33835327 | Interleukin 33 exacerbates antigen driven airway hyperresponsiveness, inflammation and remodeling in a mouse model of asthma |
Q38783993 | Interleukin 33: an innate alarm for adaptive responses beyond Th2 immunity-emerging roles in obesity, intestinal inflammation, and cancer |
Q93158285 | Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity |
Q36911822 | Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection. |
Q47285890 | Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family. |
Q90239283 | Interleukin-33 Induces the Enzyme Tryptophan Hydroxylase 1 to Promote Inflammatory Group 2 Innate Lymphoid Cell-Mediated Immunity |
Q59351894 | Interleukin-33 and ST2 Signaling in Tumor Microenvironment |
Q35754479 | Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation |
Q38957840 | Interleukin-33 in health and disease |
Q41945735 | Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis |
Q38105069 | Interleukin-33: a mediator of inflammation targeting hematopoietic stem and progenitor cells and their progenies |
Q92538732 | Interleukin-7 Receptor Alpha in Innate Lymphoid Cells: More Than a Marker |
Q48151041 | Interplay of innate lymphoid cells and the microbiota. |
Q59356082 | Intestinal Microbiota Disruption Reduces Regulatory T Cells and Increases Respiratory Viral Infection Mortality Through Increased IFNγ Production |
Q26781239 | Intestinal Microbiota and the Innate Immune System - A Crosstalk in Crohn's Disease Pathogenesis |
Q38958938 | Intestinal Transplant Inflammation: the Third Inflammatory Bowel Disease |
Q38971101 | Intestinal commensal bacteria mediate lung mucosal immunity and promote resistance of newborn mice to infection |
Q38190874 | Intestinal epithelial cells: regulators of barrier function and immune homeostasis |
Q37668196 | Intrahepatic innate lymphoid cells secrete IL-17A and IL-17F that are crucial for T cell priming in viral infection. |
Q38417709 | Intratumorally Establishing Type 2 Innate Lymphoid Cells Blocks Tumor Growth. |
Q36563630 | Intrinsic functional defects of type 2 innate lymphoid cells impair innate allergic inflammation in promyelocytic leukemia zinc finger (PLZF)-deficient mice. |
Q40082836 | Isolation of Group 2 Innate Lymphoid Cells from Mouse Lungs |
Q37703101 | Kinetics of pulmonary immune cells, antibody responses and their correlations with the viral clearance of influenza A fatal infection in mice. |
Q93360213 | Kinetics of the accumulation of group 2 innate lymphoid cells in IL-33-induced and IL-25-induced murine models of asthma: a potential role for the chemokine CXCL16 |
Q52807928 | Lack of Type 2 Innate Lymphoid Cells Promote a Type I Driven Enhanced Immune Response in Contact Hypersensitivity. |
Q41933677 | Lactobacillus paracasei feeding improves immune control of influenza infection in mice. |
Q37653825 | Lanthionine Synthetase C-Like 2 Modulates Immune Responses to Influenza Virus Infection |
Q30411194 | Late engagement of CD86 after influenza virus clearance promotes recovery in a FoxP3+ regulatory T cell dependent manner |
Q102211190 | Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19 |
Q31112685 | Limited anti-inflammatory role for interleukin-1 receptor like 1 (ST2) in the host response to murine postinfluenza pneumococcal pneumonia |
Q89182680 | Live Vaccination Generates Both Disease Tolerance and Host Resistance During Chronic Pulmonary Infection With Highly Virulent Francisella tularensis SchuS4 |
Q51017443 | Long-term Persistence of Innate Lymphoid Cells in the Gut After Intestinal Transplantation. |
Q36991150 | Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production |
Q34106637 | MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion |
Q26774652 | Macrophage and Innate Lymphoid Cell Interplay in the Genesis of Fibrosis |
Q58600016 | Macrophages promote epithelial proliferation following infectious and non-infectious lung injury through a Trefoil factor 2-dependent mechanism |
Q26796071 | Maintenance of Immune Homeostasis through ILC/T Cell Interactions |
Q38633155 | Mast cells in asthma--state of the art. |
Q52448914 | Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection. |
Q64076713 | Mechanisms of Bacterial Superinfection Post-influenza: A Role for Unconventional T Cells |
Q42339208 | Memory-type ST2+CD4+ T cells participate in the steroid-resistant pathology of eosinophilic pneumonia |
Q90050659 | Metabolic Control of Innate Lymphoid Cell Migration |
Q38130854 | Metalloproteinases and their natural inhibitors in inflammation and immunity. |
Q36554706 | Migration and Tissue Tropism of Innate Lymphoid Cells |
Q42699781 | Modulation of Signal Strength Switches Notch from an Inducer of T Cells to an Inducer of ILC2. |
Q36923660 | Myeloid-Restricted AMPKα1 Promotes Host Immunity and Protects against IL-12/23p40-Dependent Lung Injury during Hookworm Infection. |
Q98177647 | NK Cell Development in Times of Innate Lymphoid Cell Diversity |
Q26744632 | NK Cells and Other Innate Lymphoid Cells in Hematopoietic Stem Cell Transplantation |
Q58745474 | NLRP3 Inflammasome and IL-33: Novel Players in Sterile Liver Inflammation |
Q50145619 | Natural variation in the parameters of innate immune cells is preferentially driven by genetic factors. |
Q39084322 | Negative Regulation of Type 2 Immunity |
Q42213596 | Neonatal rhinovirus induces mucous metaplasia and airways hyperresponsiveness through IL-25 and type 2 innate lymphoid cells. |
Q91711799 | Neuro-Immune Circuits Regulate Immune Responses in Tissues and Organ Homeostasis |
Q57181221 | Neuroendocrine regulation of innate lymphoid cells |
Q40067858 | Neuronal regulation of type 2 innate lymphoid cells via neuromedin U. |
Q37345931 | Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice |
Q57464736 | Neutrophils Promote Amphiregulin Production in Intestinal Epithelial Cells through TGF-β and Contribute to Intestinal Homeostasis |
Q38075724 | New friendships and old feuds: relationships between innate lymphoid cells and microbial communities |
Q38400762 | New fronts emerge in the influenza cytokine storm |
Q38834168 | New insights into basophil heterogeneity |
Q64102157 | Non-cytotoxic Cardiac Innate Lymphoid Cells Are a Resident and Quiescent Type 2-Commited Population |
Q42198317 | Novel HIV IL-4R antagonist vaccine strategy can induce both high avidity CD8 T and B cell immunity with greater protective efficacy. |
Q34992604 | Novel mode of ISG15-mediated protection against influenza A virus and Sendai virus in mice |
Q40246354 | Novel protective mechanism for interleukin-33 at the mucosal barrier during influenza-associated bacterial superinfection. |
Q40816924 | Nucleotide-binding oligomerization domain 1 acts in concert with the cholecystokinin receptor agonist, cerulein, to induce IL-33-dependent chronic pancreatitis |
Q91816062 | Orchestration between ILC2s and Th2 cells in shaping type 2 immune responses |
Q47701540 | Orchestration of epithelial-derived cytokines and innate immune cells in allergic airway inflammation. |
Q39250716 | Origins and evolution of innate lymphoid cells: Wardens of barrier immunity |
Q40218537 | PD-1 regulates KLRG1+ group 2 innate lymphoid cells. |
Q39147430 | PGI2 Controls Pulmonary NK Cells That Prevent Airway Sensitization to House Dust Mite Allergen |
Q98564961 | PPARγ enhances ILC2 function during allergic airway inflammation via transcription regulation of ST2 |
Q30378115 | Pandemic influenza virus, pH1N1, induces asthmatic symptoms via activation of innate lymphoid cells. |
Q27690787 | Particle disease: biologic mechanisms of periprosthetic osteolysis in total hip arthroplasty |
Q47897160 | Pathological and therapeutic roles of innate lymphoid cells in diverse diseases |
Q35678019 | Perinatal paracetamol exposure in mice does not affect the development of allergic airways disease in early life |
Q92451412 | Peripheral lymph nodes contain migratory and resident innate lymphoid cell populations |
Q36396894 | Pertussis toxin exacerbates and prolongs airway inflammatory responses during Bordetella pertussis infection |
Q38366661 | Pivotal roles of ILCs in hepatic diseases |
Q36106065 | Plasmacytoid dendritic cells promote HIV-1-induced group 3 innate lymphoid cell depletion |
Q64069927 | Pleiotropic Effects of IL-33 on CD4 T Cell Differentiation and Effector Functions |
Q89965506 | Pleiotropic Role and Bidirectional Immunomodulation of Innate Lymphoid Cells in Cancer |
Q37704877 | Polarization of ILC2s in peripheral blood might contribute to immunosuppressive microenvironment in patients with gastric cancer |
Q52734237 | Post-injury and resolution response to repetitive inhalation exposure to agricultural organic dust in mice. |
Q58110816 | Postviral atopic airway disease: pathogenesis and potential avenues for intervention |
Q48319320 | Potentiating Tissue-Resident Type 2 Innate Lymphoid Cells by IL-33 to Prevent Renal Ischemia-Reperfusion Injury. |
Q92263907 | Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases |
Q49942221 | Preferential Reduction of Circulating Innate Lymphoid Cells Type 2 in Patients with Common Variable Immunodeficiency with Secondary Complications Is Part of a Broader Immune Dysregulation. |
Q35788740 | Prevention of Influenza Virus-Induced Immunopathology by TGF-β Produced during Allergic Asthma |
Q28084783 | Primary graft dysfunction: lessons learned about the first 72 h after lung transplantation |
Q38264905 | Priming dendritic cells for th2 polarization: lessons learned from helminths and implications for metabolic disorders |
Q41493755 | Probiotics inhibit immune fluctuation in the intestinal mucous layer in rats |
Q55715145 | Production of amphiregulin and recovery from influenza is greater in males than females. |
Q27468701 | Progesterone-Based Therapy Protects Against Influenza by Promoting Lung Repair and Recovery in Females |
Q92852963 | Programmed Cell Death-1 Receptor (PD-1)-Mediated Regulation of Innate Lymphoid Cells |
Q37730806 | Prolonged activation of IL-5-producing ILC2 causes pulmonary arterial hypertrophy |
Q51560377 | Prostacyclin as a Potential Novel Means to Manipulate Type 2 Innate Lymphoid Cell Function. |
Q37691114 | Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells |
Q37619448 | Prostaglandin D2 regulates human type 2 innate lymphoid cell chemotaxis. |
Q50025252 | Prostaglandin E2 suppresses human group 2 innate lymphoid cell function. |
Q30357197 | Protecting against post-influenza bacterial pneumonia by increasing phagocyte recruitment and ROS production. |
Q27005837 | Protection and pathology during parasite infection: IL-10 strikes the balance |
Q38734006 | Protective role of Th17 cells in pulmonary infection |
Q89621189 | Pulmonary Group 2 Innate Lymphoid Cell Phenotype Is Context Specific: Determining the Effect of Strain, Location, and Stimuli |
Q98735557 | Pulmonary Innate Immune Response Determines the Outcome of Inflammation During Pneumonia and Sepsis-Associated Acute Lung Injury |
Q92595448 | Pulmonary environmental cues drive group 2 innate lymphoid cell dynamics in mice and humans |
Q91142624 | Pulmonary group 2 innate lymphoid cells: surprises and challenges |
Q84007863 | Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma |
Q36037610 | Pulmonary receptor for advanced glycation end-products promotes asthma pathogenesis through IL-33 and accumulation of group 2 innate lymphoid cells |
Q52668415 | Pulmonary resident neutrophils regulate the production of GM-CSF and alveolar macrophages. |
Q52859608 | Putting the brakes on ILC2 cells. |
Q92641374 | RAGE-induced ILC2 expansion in acute lung injury due to haemorrhagic shock |
Q36724677 | RORγt+ cells selectively express redundant cation channels linked to the Golgi apparatus |
Q30419007 | Recent insights into pulmonary repair following virus-induced inflammation of the respiratory tract |
Q27014696 | Regulating the adaptive immune response to respiratory virus infection |
Q97521492 | Regulation of Human Innate Lymphoid Cells in the Context of Mucosal Inflammation |
Q49544001 | Regulation of Innate Lymphoid Cells by Aryl Hydrocarbon Receptor. |
Q61807003 | Regulation of Type 2 Immunity in Myocardial Infarction |
Q37313634 | Regulation of metabolic health and adipose tissue function by group 2 innate lymphoid cells |
Q26864694 | Regulation of the adaptive immune system by innate lymphoid cells |
Q43087975 | Regulatory T cells and regulation of allergic airway disease |
Q39119210 | Regulatory T cells and type 2 innate lymphoid cell-dependent asthma. |
Q35665218 | Regulatory immune cells in regulation of intestinal inflammatory response to microbiota. |
Q37728126 | Regulatory roles of dermal type 2 innate lymphoid cells |
Q35861236 | Repeated Low-Dose Influenza Virus Infection Causes Severe Disease in Mice: a Model for Vaccine Evaluation |
Q46902753 | Reply to Roux and Ricard |
Q58778332 | Resolution of chronic inflammatory disease: universal and tissue-specific concepts |
Q89965550 | Respiratory Barrier as a Safeguard and Regulator of Defense Against Influenza A Virus and Streptococcus pneumoniae |
Q35992338 | Respiratory Mucosal Proteome Quantification in Human Influenza Infections |
Q36488767 | Respiratory infection and the impact of pulmonary immunity on lung health and disease |
Q37239031 | Respiratory syncytial virus infection activates IL-13-producing group 2 innate lymphoid cells through thymic stromal lymphopoietin |
Q34066715 | Respiratory viral infection, epithelial cytokines, and innate lymphoid cells in asthma exacerbations |
Q28079922 | Respiratory viral infections and host responses; insights from genomics |
Q40906432 | Restoring cigarette smoke-induced impairment of efferocytosis in alveolar macrophages |
Q38172661 | Rhinoviral infection and asthma: the detection and management of rhinoviruses by airway epithelial cells. |
Q60935640 | Role of Epidermal Growth Factor Receptor (EGFR) and Its Ligands in Kidney Inflammation and Damage |
Q59354960 | Role of IL-18 induced Amphiregulin expression on virus induced ocular lesions |
Q61712014 | Role of Mast Cells and Type 2 Innate Lymphoid (ILC2) Cells in Lung Transplantation |
Q42150907 | Role of innate lymphocytes in infection and inflammation |
Q41974283 | Role of tissue protection in lethal respiratory viral-bacterial coinfection |
Q64943706 | Roles for T/B lymphocytes and ILC2s in experimental chronic obstructive pulmonary disease. |
Q26747318 | Roles of IL-33 in Resistance and Tolerance to Systemic Candida albicans Infections |
Q90282573 | Roles of Type 1, 2, and 3 Innate Lymphoid Cells in Herpes Simplex Virus 1 Infection In Vitro and In Vivo |
Q38832477 | Roles of basophils and mast cells in cutaneous inflammation |
Q27329934 | S. mansoni bolsters anti-viral immunity in the murine respiratory tract |
Q48306862 | S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense. |
Q36312341 | STAT6 regulates natural helper cell proliferation during lung inflammation initiated by Alternaria. |
Q48278167 | Scanning the Immunopathogenesis of Psoriasis |
Q36818009 | Selective programming of CCR10(+) innate lymphoid cells in skin-draining lymph nodes for cutaneous homeostatic regulation |
Q45401591 | Sense and Immunity: Context-Dependent Neuro-Immune Interplay. |
Q92179686 | Sensing of physiological regulators by innate lymphoid cells |
Q54209307 | Seventeen-Year Journey Working With a Master. |
Q57020537 | Sex Hormones Regulate Innate Immune Cells and Promote Sex Differences in Respiratory Virus Infection |
Q57296308 | Sex and sex steroids impact influenza pathogenesis across the life course |
Q50456111 | Single-cell Gene Expression Using Multiplex RT-qPCR to Characterize Heterogeneity of Rare Lymphoid Populations. |
Q30543593 | Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice |
Q59791476 | Social Networking of Group Two Innate Lymphoid Cells in Allergy and Asthma |
Q41683236 | Soluble ST2 suppresses the effect of interleukin-33 on lung type 2 innate lymphoid cells |
Q91631661 | Spatial and Temporal Mapping of Human Innate Lymphoid Cells Reveals Elements of Tissue Specificity |
Q28271331 | Specialized pro-resolving mediators: endogenous regulators of infection and inflammation |
Q50533261 | Stable incorporation of GM-CSF into dissolvable microneedle patch improves skin vaccination against influenza. |
Q47880159 | Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment. |
Q99248427 | Stomach microbiota, Helicobacter pylori, and group 2 innate lymphoid cells |
Q42564456 | Striking similarity: GATA-3 regulates ILC2 and Th2 cells |
Q91688048 | Structural Basis of IL-1 Family Cytokine Signaling |
Q92445194 | Suppression of Aiolos and Ikaros expression by lenalidomide reduces human ILC3-ILC1/NK cell transdifferentiation |
Q55514867 | Surviving Deadly Lung Infections: Innate Host Tolerance Mechanisms in the Pulmonary System. |
Q42002627 | T Helper Cell Differentiation, Heterogeneity, and Plasticity. |
Q35156077 | T cell contamination in flow cytometry gating approaches for analysis of innate lymphoid cells. |
Q33645561 | T cell factor 1 is required for group 2 innate lymphoid cell generation |
Q36387954 | T cell responses are elicited against Respiratory Syncytial Virus in the absence of signalling through TLRs, RLRs and IL-1R/IL-18R. |
Q59360917 | T cells and ILC2s are major effector cells in influenza-induced exacerbation of allergic airway inflammation in mice |
Q35940715 | T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production |
Q38107790 | TH2, allergy and group 2 innate lymphoid cells |
Q37721441 | TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers |
Q35581734 | TNF-α Producing Innate Lymphoid Cells (ILCs) Are Increased in Active Celiac Disease and Contribute to Promote Intestinal Atrophy in Mice |
Q36798825 | TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation |
Q39201665 | Tertiary lymphoid organs in systemic autoimmune diseases: pathogenic or protective? |
Q38081172 | Th1- and Th2-like subsets of innate lymphoid cells |
Q38101646 | Th2-type innate immune responses mediated by natural helper cells |
Q33725605 | The Absence of Interferon-β Promotor Stimulator-1 (IPS-1) Predisposes to Bronchiolitis and Asthma-like Pathology in Response to Pneumoviral Infection in Mice |
Q41874105 | The C5a/C5aR1 axis controls the development of experimental allergic asthma independent of LysM-expressing pulmonary immune cells. |
Q26743383 | The Dynamic Role of the IL-33/ST2 Axis in Chronic Viral-infections: Alarming and Adjuvanting the Immune Response |
Q98465722 | The Heterogeneity, Origins, and Impact of Migratory iILC2 Cells in Anti-helminth Immunity |
Q26752849 | The IL-1 cytokine family and its role in inflammation and fibrosis in the lung |
Q94503619 | The IL-33/ST2 Axis in Immune Responses Against Parasitic Disease: Potential Therapeutic Applications |
Q28066426 | The Immune System in Tissue Environments Regaining Homeostasis after Injury: Is "Inflammation" Always Inflammation? |
Q92239566 | The Influence of Innate Lymphoid Cells and Unconventional T Cells in Chronic Inflammatory Lung Disease |
Q40125256 | The Innate Cytokines IL-25, IL-33, and TSLP Cooperate in the Induction of Type 2 Innate Lymphoid Cell Expansion and Mucous Metaplasia in Rhinovirus-Infected Immature Mice. |
Q51835824 | The Innate Immune Response in Myocardial Infarction, Repair, and Regeneration. |
Q59329322 | The Pleiotropic Immunomodulatory Functions of IL-33 and Its Implications in Tumor Immunity |
Q52332667 | The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis. |
Q90706788 | The Role of Innate Leukocytes during Influenza Virus Infection |
Q28070412 | The Role of Lymphocytes in Radiotherapy-Induced Adverse Late Effects in the Lung |
Q26778082 | The Role of TOX in the Development of Innate Lymphoid Cells |
Q38860235 | The Roles of Type I Interferon in Bacterial Infection |
Q33593742 | The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases |
Q41906298 | The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cells. |
Q61795918 | The Tec kinase ITK is essential for ILC2 survival and epithelial integrity in the intestine |
Q38007828 | The airway epithelium in asthma |
Q38161762 | The amazing innate immune response to influenza A virus infection |
Q35167005 | The basic leucine zipper transcription factor NFIL3 directs the development of a common innate lymphoid cell precursor |
Q38319907 | The biology of innate lymphoid cells |
Q98190329 | The contribution of animal models to understanding the role of the immune system in human idiopathic pulmonary fibrosis |
Q35629731 | The development of innate lymphoid cells requires TOX-dependent generation of a common innate lymphoid cell progenitor |
Q90208339 | The emerging roles of eosinophils in mucosal homeostasis |
Q38071241 | The evolutionary role of the IL-33/ST2 system in host immune defence |
Q26766467 | The host immune response in respiratory virus infection: balancing virus clearance and immunopathology. |
Q36055988 | The human side of influenza |
Q41673436 | The immunology of asthma |
Q28084679 | The immunology of influenza virus-associated bacterial pneumonia |
Q38981754 | The inflammatory response triggered by Influenza virus: a two edged sword. |
Q92556136 | The intersection of sex and gender in the treatment of influenza |
Q35584727 | The meninges: new therapeutic targets for multiple sclerosis |
Q38271331 | The messenger between worlds: the regulation of innate and adaptive type-2 immunity by innate lymphoid cells |
Q47095124 | The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation. |
Q40067864 | The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation. |
Q26740079 | The origin and role of innate lymphoid cells in the lung |
Q40103784 | The orphan nuclear receptor RORα and group 3 innate lymphoid cells drive fibrosis in a mouse model of Crohn's disease |
Q36137414 | The prostaglandin D₂ receptor CRTH2 regulates accumulation of group 2 innate lymphoid cells in the inflamed lung. |
Q92131178 | The protective and pathogenic roles of IL-17 in viral infections: friend or foe? |
Q38042722 | The role of Helicobacter pylori infection in the development of allergic asthma |
Q54224246 | The role of IL-22 in the resolution of sterile and nonsterile inflammation. |
Q39215742 | The role of ILC2 in hookworm infection. |
Q36663025 | The role of airway epithelial cells and innate immune cells in chronic respiratory disease |
Q48146269 | The role of innate lymphoid cells in health and disease |
Q89665184 | The role of innate lymphoid cells in response to microbes at mucosal surfaces |
Q40184625 | The role of rare innate immune cells in Type 2 immune activation against parasitic helminths. |
Q57824353 | The role of respiratory epithelium in host defence against influenza virus infection |
Q38115440 | The role of the immune system in governing host-microbe interactions in the intestine |
Q26995991 | The role of type 2 innate lymphoid cells in asthma |
Q89282567 | The roles for innate lymphoid cells in the human immune system |
Q34105699 | The roles of innate lymphoid cells in the development of asthma |
Q35671263 | The transcription factor Bcl11b is specifically expressed in group 2 innate lymphoid cells and is essential for their development |
Q40990833 | The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. |
Q33634144 | The transcription factor GATA3 is critical for the development of all IL-7Rα-expressing innate lymphoid cells |
Q45004480 | Thy1+ Sca1+ innate lymphoid cells infiltrate the CNS during autoimmune inflammation, but do not contribute to disease development |
Q36545986 | Thymic stromal lymphopoietin amplifies the differentiation of alternatively activated macrophages |
Q53085315 | Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation. |
Q48143276 | Tissue microenvironment dictates the fate and tumor-suppressive function of type 3 ILCs |
Q36085091 | Tissue resident regulatory T cells: novel therapeutic targets for human disease |
Q63246320 | Tissue-Resident Innate and Innate-Like Lymphocyte Responses to Viral Infection |
Q55284399 | Tissue-Restricted Adaptive Type 2 Immunity Is Orchestrated by Expression of the Costimulatory Molecule OX40L on Group 2 Innate Lymphoid Cells. |
Q26741570 | Tissue-specific contribution of macrophages to wound healing |
Q38089253 | Tissue-specific effector functions of innate lymphoid cells. |
Q64098123 | Topical Application of the Quaternary Ammonium Compound Didecyldimethylammonium Chloride Activates Type 2 Innate Lymphoid Cells and Initiates a Mixed-Type Allergic Response |
Q36311181 | Transcription Factor Bcl11b Controls Identity and Function of Mature Type 2 Innate Lymphoid Cells |
Q64076242 | Transcription Factors in the Development and Function of Group 2 Innate Lymphoid Cells |
Q38192561 | Transcription factors controlling development and function of innate lymphoid cells |
Q26785671 | Transcriptional Regulatory Network for the Development of Innate Lymphoid Cells |
Q27005868 | Transcriptional control of innate lymphoid cells |
Q38525099 | Transcriptional regulation of innate lymphoid cell fate. |
Q37712418 | Transcriptional regulators dictate innate lymphoid cell fates |
Q91810892 | Transcriptome Meta-Analysis Deciphers a Dysregulation in Immune Response-Associated Gene Signatures during Sepsis |
Q40328781 | Transcriptomic Analysis of the Innate Antiviral Immune Response in Porcine Intestinal Epithelial Cells: Influence of Immunobiotic Lactobacilli. |
Q96137704 | Treg regulation of the epithelial stem cell lineage |
Q47669026 | Type 2 Cysteinyl Leukotriene Receptors Drive IL-33-Dependent Type 2 Immunopathology and Aspirin Sensitivity. |
Q38216020 | Type 2 Innate Lymphoid Cells in Allergic Disease |
Q64251722 | Type 2 Innate Lymphoid Cells in Liver and Gut: From Current Knowledge to Future Perspectives |
Q37213084 | Type 2 immunity and wound healing: evolutionary refinement of adaptive immunity by helminths. |
Q38096872 | Type 2 innate lymphocytes in allergic airway inflammation |
Q57181216 | Type 2 innate lymphoid cells in the induction and resolution of tissue inflammation |
Q41896478 | Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease |
Q84007849 | Type 2 innate lymphoid cells-new members of the "type 2 franchise" that mediate allergic airway inflammation |
Q26766464 | Type 2 innate lymphoid cells: at the cross-roads in allergic asthma |
Q38064849 | Type 2 innate lymphoid cells: friends or foes-role in airway allergic inflammation and asthma |
Q61807031 | Type 3 ILCs in Lung Disease |
Q42242747 | Type I interferon plays opposing roles in cytotoxicity and interferon-γ production by natural killer and CD8 T cells after influenza A virus infection in mice. |
Q40899547 | Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells |
Q39402904 | Type two innate lymphoid cells: the Janus cells in health and disease. |
Q38294532 | Type-2 innate lymphoid cells in asthma and allergy |
Q38239232 | Type-2 innate lymphoid cells in human allergic disease |
Q88406488 | T cell-derived IFN-γ downregulates protective group 2 innate lymphoid cells in murine lupus erythematosus |
Q47100895 | Unique transcriptome signatures and GM-CSF expression in lymphocytes from patients with spondyloarthritis. |
Q39123548 | Unravelling the networks dictating host resistance versus tolerance during pulmonary infections. |
Q38218882 | Update on innate lymphoid cells in atopic and non-atopic inflammation in the airways and skin |
Q64074371 | Uterine Natural Killer Cells |
Q54105139 | Vaccination route can significantly alter the innate lymphoid cell subsets: a feedback between IL-13 and IFN-γ. |
Q30409296 | Viral infection of the lung: host response and sequelae |
Q38172663 | Viral respiratory tract infections and asthma in early life: cause and effect? |
Q28079656 | When Insult Is Added to Injury: Cross Talk between ILCs and Intestinal Epithelium in IBD |
Q89167812 | Why Innate Lymphoid Cells? |
Q68624456 | [Bone marrow hematopoiesis. Evaluation of the myelogram] |
Q50673833 | [Innate lymphoid cells: new players of the mucosal immune response]. |
Q52765682 | [Innate lymphoid cells]. |
Search more.